中(zhong)(zhong)(zhong)國(guo)(guo)基層(ceng)網新(xin)疆(jiang)12月8日訊(xun)(于熙(xi))為深入貫徹(che)和(he)(he)習近(jin)平(ping)總書記對中(zhong)(zhong)(zhong)醫藥(yao)工作重(zhong)(zhong)(zhong)要指示，12月7日，由中(zhong)(zhong)(zhong)國(guo)(guo)中(zhong)(zhong)(zhong)藥(yao)協(xie)會主辦、清(qing)華大(da)學生命(ming)科學院、中(zhong)(zhong)(zhong)國(guo)(guo)民族醫藥(yao)協(xie)會等單(dan)位(wei)協(xie)辦的(de)國(guo)(guo)家(jia)重(zhong)(zhong)(zhong)大(da)新(xin)藥(yao)創(chuang)制(zhi)·科技重(zhong)(zhong)(zhong)大(da)專項”抗抑郁中(zhong)(zhong)(zhong)藥(yao)創(chuang)新(xin)藥(yao)“太子神悅(yue)”重(zhong)(zhong)(zhong)大(da)成(cheng)果發布(bu)會，在新(xin)疆(jiang)首府烏魯木(mu)齊隆重(zhong)(zhong)(zhong)舉行。中(zhong)(zhong)(zhong)國(guo)(guo)中(zhong)(zhong)(zhong)醫藥(yao)界的(de)專家(jia)學者、全國(guo)(guo)知(zhi)名投(tou)資機構、自治區有關單(dan)位(wei)的(de)領導、自治區和(he)(he)兵團相關企業代表(biao)、金融機構以(yi)及各(ge)界嘉賓約(yue)百人參(can)加了會議。

習近平總書記(ji)在對中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)工作重要指示中(zhong)(zhong)(zhong)強調(diao)，要遵(zun)循(xun)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)發(fa)展規律(lv)，傳承精(jing)華(hua)，守正創新，加快推(tui)(tui)進中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)現(xian)代化、產業(ye)化，推(tui)(tui)動(dong)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)事業(ye)和(he)(he)產業(ye)高質量(liang)發(fa)展，推(tui)(tui)動(dong)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)走向世界，充分發(fa)揮中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)防病治病的獨特優勢和(he)(he)作用，為建設健康中(zhong)(zhong)(zhong)國、實(shi)現(xian)中(zhong)(zhong)(zhong)華(hua)民族偉大復興的中(zhong)(zhong)(zhong)國夢貢(gong)獻力量(liang)。

首先(xian)，受中(zhong)國(guo)(guo)工程院(yuan)院(yuan)士(shi)、中(zhong)國(guo)(guo)中(zhong)藥(yao)(yao)協(xie)會黃潞琦會長委托，中(zhong)國(guo)(guo)中(zhong)藥(yao)(yao)協(xie)會常務副會長劉張林先(xian)生致辭，他說，歷經(jing)17年的艱辛(xin)努力(li)(li)，在(zai)(zai)國(guo)(guo)家衛計委、科(ke)技部、國(guo)(guo)家藥(yao)(yao)監局(ju)、新疆(jiang)(jiang)維吾(wu)爾自(zi)治區人民政府高度(du)重視(shi)與大力(li)(li)支持(chi)下，由(you)清華大學(xue)、新疆(jiang)(jiang)華春生物藥(yao)(yao)業股份有限(xian)公司共同研發的中(zhong)國(guo)(guo)原(yuan)創(chuang)性抗抑(yi)郁中(zhong)藥(yao)(yao)創(chuang)新藥(yao)(yao)太(tai)子(zi)(zi)神(shen)悅(yue)順利完成三期臨床研究總結(jie)，結(jie)果顯示(shi)，太(tai)子(zi)(zi)神(shen)悅(yue)膠囊的有效率(lv)為75.14%，與經(jing)典化(hua)學(xue)西藥(yao)(yao)相當，而在(zai)(zai)安全性以(yi)及癥候改善方面太(tai)子(zi)(zi)神(shen)悅(yue)具有明顯優勢，充分(fen)體(ti)現了中(zhong)醫(yi)藥(yao)(yao)在(zai)(zai)精神(shen)神(shen)經(jing)疾病領域的特色與生命力(li)(li)。

抑(yi)郁癥已經成(cheng)為全(quan)球致(zhi)殘率第一的(de)重(zhong)大疾患(huan)，并已超(chao)過(guo)心腦血(xue)管(guan)病成(cheng)為全(quan)球第二(er)大疾病。太子神悅階段性(xing)重(zhong)大成(cheng)果是中醫(yi)藥(yao)事業發展(zhan)重(zhong)要的(de)代(dai)表(biao)性(xing)進(jin)展(zhan)，填(tian)補了中國抗(kang)抑(yi)郁中藥(yao)原創性(xing)新藥(yao)創制的(de)空白(bai)，必將對新疆(jiang)中醫(yi)藥(yao)產(chan)業以及區域優勢中藥(yao)材種植業的(de)快速發展(zhan)產(chan)生(sheng)重(zhong)大影響，同時(shi)對于推動(dong)中醫(yi)藥(yao)現代(dai)化也將具有里(li)程碑意義!

劉張(zhang)林表示，中(zhong)(zhong)(zhong)(zhong)國中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)協(xie)會由國家中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)管理局主管，其宗旨(zhi)是弘揚(yang)中(zhong)(zhong)(zhong)(zhong)華中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)文化(hua)，推動(dong)中(zhong)(zhong)(zhong)(zhong)醫(yi)藥(yao)(yao)創新(xin)與產業(ye)發展。中(zhong)(zhong)(zhong)(zhong)國中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)協(xie)會將針對太子神(shen)悅膠囊新(xin)藥(yao)(yao)的加快注冊、納入醫(yi)保、加快產業(ye)化(hua)發展等各方(fang)面給(gei)予全方(fang)位鼎(ding)力支持，切實推動(dong)這一(yi)成果早日(ri)造(zao)福(fu)全球抑郁癥(zheng)患(huan)者，為(wei)增進人民健康福(fu)祉作出貢(gong)獻!

新(xin)疆(jiang)華春(chun)生(sheng)物藥(yao)(yao)(yao)(yao)業股份有(you)(you)(you)限(xian)公司與清華大學生(sheng)命科學院經過17年的(de)(de)艱辛努力，共(gong)同研(yan)發的(de)(de)中(zhong)(zhong)(zhong)國(guo)有(you)(you)(you)效(xiao)部位(wei)群抗(kang)抑郁(yu)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)創(chuang)新(xin)藥(yao)(yao)(yao)(yao)，順利結(jie)束(shu)三(san)期臨(lin)床(chuang)研(yan)究，并(bing)完成(cheng)三(san)期臨(lin)床(chuang)研(yan)究總結(jie)報告。太(tai)(tai)子(zi)(zi)神(shen)(shen)悅(yue)(yue)膠(jiao)囊與對照(zhao)藥(yao)(yao)(yao)(yao)西(xi)藥(yao)(yao)(yao)(yao)效(xiao)率相當(dang)，西(xi)藥(yao)(yao)(yao)(yao)有(you)(you)(you)效(xiao)率為(wei)73.55%，太(tai)(tai)子(zi)(zi)神(shen)(shen)悅(yue)(yue)膠(jiao)囊有(you)(you)(you)效(xiao)率為(wei)75.14%，但太(tai)(tai)子(zi)(zi)神(shen)(shen)悅(yue)(yue)其安(an)全(quan)性(xing)(xing)更高。屬于(yu)效(xiao)果(guo)明顯、安(an)全(quan)性(xing)(xing)高的(de)(de)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)抗(kang)抑郁(yu)類(lei)新(xin)藥(yao)(yao)(yao)(yao)。臨(lin)床(chuang)療(liao)效(xiao)以及(ji)安(an)全(quan)性(xing)(xing)結(jie)果(guo)得到了(le)十多家國(guo)家級臨(lin)床(chuang)藥(yao)(yao)(yao)(yao)理基地(di)的(de)(de)高度(du)肯定，是治(zhi)療(liao)輕、中(zhong)(zhong)(zhong)度(du)抑郁(yu)癥的(de)(de)純中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)新(xin)藥(yao)(yao)(yao)(yao)，現(xian)已進(jin)入(ru)新(xin)藥(yao)(yao)(yao)(yao)的(de)(de)注冊報批階段，“太(tai)(tai)子(zi)(zi)神(shen)(shen)悅(yue)(yue)”階段性(xing)(xing)重大成(cheng)果(guo)填補(bu)了(le)新(xin)疆(jiang)抗(kang)抑郁(yu)新(xin)藥(yao)(yao)(yao)(yao)創(chuang)制的(de)(de)空(kong)白，必將帶(dai)動新(xin)疆(jiang)中(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)產業以及(ji)新(xin)疆(jiang)區(qu)域優勢中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)種植產業的(de)(de)規模化快(kuai)速發展，同時對于(yu)推動中(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)現(xian)代(dai)化也將具有(you)(you)(you)里程碑意義(yi)，該新(xin)藥(yao)(yao)(yao)(yao)將成(cheng)為(wei)抗(kang)抑郁(yu)癥醫藥(yao)(yao)(yao)(yao)市場的(de)(de)重磅新(xin)藥(yao)(yao)(yao)(yao)。華春(chun)藥(yao)(yao)(yao)(yao)業被定為(wei)新(xin)疆(jiang)創(chuang)新(xin)百強企業、擬上市重點(dian)培育企業。

會上，中(zhong)國(guo)著(zhu)名中(zhong)藥(yao)(yao)藥(yao)(yao)理專(zhuan)(zhuan)(zhuan)(zhuan)家(jia)(jia)葉祖光教(jiao)(jiao)授(shou)(shou)(shou);國(guo)家(jia)(jia)藥(yao)(yao)品監督管(guan)理局(ju)(ju)與(yu)國(guo)家(jia)(jia)科(ke)技部新(xin)(xin)藥(yao)(yao)專(zhuan)(zhuan)(zhuan)(zhuan)項(xiang)評審(shen)委員和(he)論證專(zhuan)(zhuan)(zhuan)(zhuan)家(jia)(jia)孫(sun)曉波(bo)教(jiao)(jiao)授(shou)(shou)(shou);清華(hua)大(da)學生命科(ke)學院邢東明(ming)教(jiao)(jiao)授(shou)(shou)(shou);國(guo)家(jia)(jia)食品藥(yao)(yao)品監督管(guan)理局(ju)(ju)新(xin)(xin)藥(yao)(yao)審(shen)評專(zhuan)(zhuan)(zhuan)(zhuan)家(jia)(jia)李樂華(hua)教(jiao)(jiao)授(shou)(shou)(shou);從事新(xin)(xin)藥(yao)(yao)臨床研(yan)究(jiu)(jiu)和(he)新(xin)(xin)藥(yao)(yao)注冊的(de)喬春生博士;醫學博士研(yan)究(jiu)(jiu)生導師劉中(zhong)國(guo)教(jiao)(jiao)授(shou)(shou)(shou)等著(zhu)名專(zhuan)(zhuan)(zhuan)(zhuan)家(jia)(jia)，就國(guo)家(jia)(jia)“重大(da)新(xin)(xin)藥(yao)(yao)創(chuang)制·科(ke)技重大(da)專(zhuan)(zhuan)(zhuan)(zhuan)項(xiang)”華(hua)春抗抑郁中(zhong)藥(yao)(yao)創(chuang)新(xin)(xin)藥(yao)(yao)，分別做(zuo)主題報(bao)告，吸引了眾多國(guo)內一流知名專(zhuan)(zhuan)(zhuan)(zhuan)家(jia)(jia)。

“重(zhong)(zhong)大新藥創(chuang)制(zhi)”科技重(zhong)(zhong)大專項,以(yi)實際(ji)應用(yong)和產業發展(zhan)為(wei)導(dao)向，其(qi)主要目標為(wei)針(zhen)對嚴重(zhong)(zhong)危害我(wo)國(guo)人民健康(kang)的惡性腫瘤、精神性疾(ji)病(bing)等10種重(zhong)(zhong)大疾(ji)病(bing)，研制(zhi)一批重(zhong)(zhong)大藥物，完善國(guo)家藥物創(chuang)新體系，提升自主創(chuang)新能(neng)力，加速我(wo)國(guo)由仿(fang)制(zhi)向創(chuang)制(zhi)、由醫藥大國(guo)向強國(guo)的轉變。

現中(zhong)(zhong)國市場(chang)上的(de)抗(kang)抑(yi)(yi)郁(yu)藥(yao)(yao)物(wu)主(zhu)(zhu)要(yao)是西(xi)藥(yao)(yao)，不(bu)但藥(yao)(yao)價高、治(zhi)療(liao)周(zhou)期長(chang)，而(er)且(qie)毒副作用(yong)大(da)。而(er)華春藥(yao)(yao)業發(fa)(fa)揚了中(zhong)(zhong)醫藥(yao)(yao)的(de)傳統優(you)勢、利用(yong)新(xin)疆獨特的(de)天然(ran)藥(yao)(yao)業資(zi)源(yuan)優(you)勢，研(yan)發(fa)(fa)的(de)抗(kang)抑(yi)(yi)郁(yu)中(zhong)(zhong)藥(yao)(yao)“太(tai)子(zi)神悅膠囊(nang)”總有(you)效率不(bu)但與抗(kang)抑(yi)(yi)郁(yu)主(zhu)(zhu)流(liu)西(xi)藥(yao)(yao)相當，而(er)且(qie)具有(you)明(ming)顯的(de)安全性和有(you)效性，還具有(you)養生、治(zhi)未病(bing)功效。避免了西(xi)藥(yao)(yao)治(zhi)療(liao)抑(yi)(yi)郁(yu)癥的(de)缺陷，優(you)勢顯著(zhu)，一旦面世(shi)，該(gai)新(xin)藥(yao)(yao)將可打(da)破國外藥(yao)(yao)品長(chang)期對中(zhong)(zhong)國抑(yi)(yi)郁(yu)癥市場(chang)的(de)壟斷，將造福巨大(da)的(de)抑(yi)(yi)郁(yu)癥群體(ti)，市場(chang)前景無量(liang)。

新(xin)疆華(hua)春(chun)生物藥(yao)(yao)(yao)業(ye)(ye)李成功總裁說：華(hua)春(chun)藥(yao)(yao)(yao)業(ye)(ye)作(zuo)為(wei)新(xin)疆的(de)(de)百(bai)強企(qi)業(ye)(ye)和擬上市重點培育企(qi)業(ye)(ye)，我們要把習近平總書(shu)記強調的(de)(de)“傳承精(jing)華(hua)、守正創(chuang)新(xin)”作(zuo)為(wei)醫(yi)藥(yao)(yao)(yao)產(chan)業(ye)(ye)發展(zhan)的(de)(de)指南，華(hua)春(chun)團隊始終以(yi)創(chuang)新(xin)的(de)(de)精(jing)神，確(que)定(ding)了以(yi)中藥(yao)(yao)(yao)產(chan)業(ye)(ye)為(wei)發展(zhan)方向，矢(shi)志不移，利用(yong)新(xin)疆獨(du)特(te)的(de)(de)天然藥(yao)(yao)(yao)業(ye)(ye)資源優(you)(you)勢，發揚中醫(yi)藥(yao)(yao)(yao)的(de)(de)傳統優(you)(you)勢，全力投身(shen)于把新(xin)疆藥(yao)(yao)(yao)業(ye)(ye)資源優(you)(you)勢變(bian)為(wei)醫(yi)藥(yao)(yao)(yao)產(chan)業(ye)(ye)優(you)(you)勢的(de)(de)偉大事業(ye)(ye)之中，促使國(guo)家(jia)重大新(xin)藥(yao)(yao)(yao)創(chuang)制·科技重大專(zhuan)項中藥(yao)(yao)(yao)創(chuang)新(xin)藥(yao)(yao)(yao)太子神悅早(zao)日(ri)實現產(chan)業(ye)(ye)化;早(zao)日(ri)造福人類;早(zao)日(ri)為(wei)新(xin)疆的(de)(de)經濟發展(zhan)和社(she)會穩定(ding)做出應有的(de)(de)貢獻(xian)!